Fabian Müller

11PUBLICATIONS
24CO-AUTHORS
Biomolecular modelling and designEpidemiological modellingMolecular medicineMolecular targetsCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 04, 2026
Effects of Trimethoprim on Three Previously Proposed Putative Biomarkers for OCT2/MATE-Mediated Renal Drug-Drug Interactions in Healthy Volunteers.

|Jun 21, 2026
The Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of a Single Oral Dose of Zongertinib in Healthy Male Volunteers.

|Dec 05, 2025
Absorption, Metabolism, Distribution and Excretion (ADME) and Absolute Bioavailability Assessment of Zongertinib in Healthy Male Volunteers.

Rolf Grempler, David Joseph, Guanfa Gan

|Oct 08, 2025
Nonclinical and Clinical Assessments of an Optimized Tablet Formulation of the Novel HER2-Selective Tyrosine Kinase Inhibitor Zongertinib: Focus on Relative Bioavailability and Impact of Variation of Gastric pH.

Stefan Wölke, Behbood Sadrolhefazi, Habib Esmaeili

|Dec 27, 2024
The effect of carbamazepine, a strong CYP3A inducer, on the pharmacokinetics of zongertinib in healthy male volunteers.

Xiaofan Tian, Habib Esmaeili, David Minich

|Aug 16, 2024
New Biomarkers for Renal Transporter-Mediated Drug-Drug Interactions: Metabolomic Effects of Cimetidine, Probenecid, Verapamil, and Rifampin in Humans.

Arne Gessner, Jörg König, Pia Wenisch

Pageof 2

Frequent Collaborators

4 joint publications

Martin F Fromm

4 joint publications

Arne Gessner

3 joint publications

Peter Stopfer

3 joint publications

Jörg König